Research at the Clínic

The Radiotherapy Oncology Department at Hospital Clínic promotes research in the field of Oncology and Haematology through the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), more specifically, the Diagnostics and Therapeutics in Oncology and Translational Genomics and Targeted Therapies in Solid Tumours group. 

Research at the Radiation Oncology Department aims to improve the response to cancer treatment and reduce side effects by personalising radiotherapy treatment based on state-of-the-art diagnostic and therapeutic technology. 

The main lines of research at the department are: 

• Identifying new therapeutic strategies through personalised molecular diagnostics. 
• Optimising radiotherapy treatment using biological toxicity models. 

Research activity is carried out in the following areas: 

• Clinical research (SBRT in lung cancer and oligometastatic cancer, extreme hypofractionation in breast and prostate tumours, intraoperative radiotherapy, etc.). 
• Participation in national and international clinical trials. The Department has a Clinical Trials Unit that is shared with the Haematology and Medical Oncology Services (Embrace, Combination of VMAT and new molecules in head and neck and pulmonary combination of radical radiotherapy with systemic treatments (SBRT, immunotherapies and targeted therapies) SBRT in lung tumours, oligometastatic SBRT, extreme hypofraction in prostate tumours, etc.). 
• Translational research: Radiogenomics in breast cancer 
• Research in medical physics: Improvement of mathematical models used to calculate highly complex radiotherapy treatments, in vivo verification of gynaecological brachytherapy treatments and intraoperative radiotherapy.